Neogen Chemicals has received an approval for the issuance of up to 16,04,710 equity shares on preferential basis at an issue price of Rs 1,402.12 per equity share aggregating to approximately Rs 225 crore.
Neogen has demonstrated its expertise across multiple chemistries including complex chemicals in the existing line of businesses, namely Organic Chemicals and Inorganic Chemicals. In addition to this, Neogen foresees significant opportunities emerging in advance intermediates, custom synthesis and new application for its expertise in lithium chemistry for manufacturing lithium-ion battery materials, required for manufacturing Advance Chemistry Cells for Lithium Ion Batteries having applications for Energy Storage for Renewables as well as for rapidly expanding Electric Vehicle (EV). The objective of this fund raise is to support the company's growth and to capture the upcoming high potential opportunities in these segments.
The equity infusion will further strengthen the company’s balance sheet position while making it future ready, to tap the growing needs of key end user industries. The Board of Directors of the company, at its meeting held on December 9, 2021, has approved the issuance of the same.
Neogen Chemicals is one of India’s leading manufacturers of bromine-based, and lithium-based, specialty chemicals.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: